Announcement Details

Lupin Limited announced its debut on TIME and Statista's World's Most Sustainable Companies 2026 list, recognizing the company's continued progress in environmental stewardship, responsible business practices, strong governance and positive social impact.

Ranking and Selection Criteria

  • Lupin ranked 318th among 750 companies selected from more than 5,000 of the world's largest and most influential organizations
  • The assessment evaluated companies across more than 20 sustainability indicators, covering sustainability commitments and ratings, reporting transparency, and environmental and social performance
  • Lupin is among 16 Indian companies included in this year's global ranking

Management Commentary

Ramesh Swaminathan, Executive Director, Global CFO, Head of IT and API Plus SBU, Lupin, stated: "Our inclusion in TIME and Statista's World's Most Sustainable Companies 2026 marks an important recognition for us. Sustainability is central to how we drive performance while advancing our purpose. We remain committed to accelerating our climate transition, strengthening governance and transparency, scaling renewable energy, and integrating ESG enterprise-wide."

ESG Performance Background

The recognition reflects Lupin's sustained efforts to integrate ESG priorities across its global operations and create long-term value for patients, communities and other stakeholders. It builds on the company's strong ESG performance, including:

  • CDP's highest 'A' leadership rating for both Climate Change and Water Security
  • S&P Global Corporate Sustainability Assessment score of 91 in 2025

Company Overview

Lupin Limited is a global pharmaceutical leader headquartered in Mumbai, India, with products distributed in over 100 markets. The company specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients.

Operational Scale

  • 15 state-of-the-art manufacturing sites globally
  • 7 research centers globally
  • Over 24,000 professionals workforce
  • Strong position in India and the U.S. across multiple therapy areas including respiratory, cardiovascular, anti-diabetic, anti-infective, gastrointestinal, central nervous system, and women's health

Subsidiaries

  • Lupin Diagnostics
  • Lupin Digital Health
  • Lupin Manufacturing Solutions